Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for prevention of postoperative delirium in elderly oral cancer patients
ChiCTR-IPR-15006101Phase 4Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in postoperative delirium (POD) (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoints: Interleukin-6, C-reactive protein and 3 more. Planned start Mar 2015; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR-IPR-15006101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006101.